DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.
>>5 Big Trades for Post-Taper Gains
Just take a look at some of the hot movers in the under-$10 complex from Thursday, including Alimera Sciences (ALIM), which is skyrocketing higher by over 60%; pSivida (PSDV), which is soaring higher by over 40%; Oxygen Biotherapeutics (OXBT), which is ripping higher by over 30%; and Astrotech (ASTC), which is spiking higher by over 20%. You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.
One low-priced stock that recently exploded higher was trucking player YRC Worldwide (YRCW), which I highlighted in Dec. 12's "5 Stocks Under $10 Set to Soar" at $9.70 per share. I mentioned in that piece that shares of YRC Worldwide had been downtrending badly for the last five months, with shares plunging lower from $33.89 to $7.06 a share. Shares of YRCW had recently formed a triple bottom chart pattern over the last month, at $7.06, $7.20 and $7.44 a share. The stock had started to reverse its downtrend and enter a new uptrend since forming that triple bottom, with shares moving higher from $7.06 to $10.50 a share. That move was starting to push shares of YRCW within range of triggering a big breakout trade above some near-term overhead resistance levels at $10.63 to its 50-day moving average of $10.87 a share.
Best Trucking Stocks To Invest In 2015: Warren Resources Inc.(WRES)
Warren Resources, Inc., an independent energy company, engages in the exploration, development, and production of onshore crude oil and gas reserves in the United States. It primarily explores for oil reserves in the Wilmington field in California; and natural gas in the Washakie Basin in Wyoming. The company was founded in 1990 and is headquartered in New York, New York.
Advisors' Opinion:- [By gurujx]
Warren Resources, Inc. (WRES): Vice President & CFO Stewart P Skelly Sold 54,000 Shares
Vice President & CFO Stewart P Skelly sold 54,000 shares of WRES stock on 09/19/2013 at the average price of $2.91. Stewart P Skelly owns at least 116,545 shares after this. The price of the stock has increased by 1.37% since.
- [By Rich Smith]
New York City-based Warren Resources (NASDAQ: WRES ) has a new CFO.
On Monday, the independent oil and gas company announced that it has promoted current Chief Financial Officer Timothy A. Larkin to the position of executive vice president for mergers�and acquisitions, after 18 years' service in the former capacity. Taking his place will be Corporate Controller Stewart P. Skelly, now promoted to the CFO's post.
Best Trucking Stocks To Invest In 2015: Morgan Stanley Emerging Markets Fund Inc. (MSF)
Morgan Stanley Emerging Markets Fund, Inc. is a closed-ended equity mutual fund launched and managed by Morgan Stanley Investment Management Inc. It invests in the public equity markets across the global emerging markets. The fund invests in stocks of companies operating across diversified sectors. It makes its investments in companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the MSCI Emerging Markets Free Index. Morgan Stanley Emerging Markets Fund Inc. was formed on November 1, 1991 and is domiciled in the United States.
Advisors' Opinion:- [By George Putnam, Editor, New Generation Research, Inc.]
Morgan Stanley Emerging Markets Fund (MSF) is not an index-based fund, and therefore, its portfolio managers have a lot of latitude.
Among their top ten holdings are a range of consumer and technology holdings, such as Samsung Electronics and Taiwan Semiconductor, as well as financials. At current prices, the fund is trading at a roughly 10.5% discount to its net asset value (NAV).
Hot Oil Service Companies To Watch For 2015: Exelixis Inc.(EXEL)
Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer. It focuses on developing Cabozantinib, an inhibitor of tumor growth, metastasis, and angiogenesis that target MET, VEGFR2, and RET, which are key kinases involved in the development and progression of various cancers. The cabozantinib is in Phase III clinical trial for the treatment for medullary thyroid cancer. The company also engages in various clinical programs for cabozantinib focused on the treatment of metastatic castration-resistant prostate cancer, ovarian cancer, breast cancer, renal cell carcinoma, non-small cell lung cancer, hepatocellular cancer, and melanoma. In addition, Exelixis, Inc. involves in developing a portfolio of other novel compounds to address serious unmet medical needs through collaborations with various pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, sanofi-aventis, Genentech, Inc., Boehringer Ingelheim Gm bH, and GlaxoSmithKline and Daiichi Sankyo Company Limited. Its products under development through collaborations include XL475, XL281, XL139, and XL413 inhibitors; ROR antagonists; therapies targeted against LXR, a nuclear hormone receptor implicated in various cardiovascular and metabolic disorders; XL147, XL765, and isoform-selective PI3K inhibitors; XL518, a small-molecule inhibitor of MEK; sphingosine-1-phosphate type 1 receptor; XL880 inhibitor; and therapies targeted against the mineralocorticoid receptor, a nuclear hormone receptor implicated in various cardiovascular and metabolic diseases. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 biotechnology player that's starting to trend within range of triggering a near-term breakout trade is Exelixis (EXEL), which develops small molecule therapies for the treatment of cancer in the U.S. This stock has been crushed by the bears so far in 2014, with shares down sharply by 41%.
If you look at the chart for Exelixis, you'll notice that EXEL has been trending sideways and consolidating for the last two months and change, with shares moving between $3.02 on the downside and $3.84 on the upside. Shares of EXEL are starting to spike higher today right off its 50-day moving average of $3.42 a share. That spike is quickly pushing shares of EXEL within range of triggering a near-term breakout trade above some key overhead resistance levels.
Market players should now look for long-biased trades in EXEL if it manages to break out above some near-term overhead resistance levels at $3.55 to $3.63 a share and then once it clears more resistance at $3.84 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 4.85 million shares. If that breakout kicks off soon, then EXEL will set up to re-test or possibly take out its next major overhead resistance level at its March gap-down-day high of $4.50 a share. Any high-volume move above $4.50 will then give EXEL a chance to re-fill some of its previous gap-down-day zone that started at $6.66 a share.
Traders can look to buy EXEL off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.18 to $3.02 a share. One can also buy EXEL off strength once it starts to move above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Selena Maranjian]
D. E. Shaw reduced its stake in lots of companies, including Acadia Pharmaceuticals (NASDAQ: ACAD ) and Exelixis (NASDAQ: EXEL ) . Acadia has skyrocketed over the past year, rising more than 10-fold, on high hopes for its pimavanserin drug, which treats psychosis in patients with Parkinson's disease. If the drug gains FDA approval, it will enjoy little competition and could be a big winner for Acadia. The company thinks the drug might be effective against psychosis related to Alzheimer's disease as well and is conducting trials for that, too. Acadia is also raising about $100 million via a secondary stock offering to fund ongoing and future trials.
- [By Garrett Cook]
Exelixis (NASDAQ: EXEL) shares shot up 4.96 percent to $3.49 after the company announced positive phase 3 data for coBRIM.
Shares of Kandi Technolgies Group (NASDAQ: KNDI) got a boost, shooting up 10.45 percent to $16.26 on report of a 238% rise in EV sales.
Best Trucking Stocks To Invest In 2015: Perrigo Company PLC (PRGO)
Perrigo Company plc, incorporated on March 23, 1988, is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. The Company�� businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia, and distributes into dozens of other markets worldwide, including Canada, China and Latin America. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.
The Company operates through several wholly owned subsidiaries. In the United States, its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., PBM Products, LLC, PBM Nutritionals, LLC, Paddock Laboratories, LLC, Perrigo Diabetes Care, LLC (formerly CanAm Care, LLC), Sergeant's Pet Care Products, Inc. and Fidopharm, Inc. Outside the United States, its operations are conducted primarily through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Laboratorios Diba, S.A., Wrafton Laboratories Limited, Galpharm Healthcare Ltd., Orion Laboratories Pty Ltd and Rosemont Pharmaceuticals Ltd.
Consumer Healthcare
Perrigo Consumer Healthcare (CHC) operation includes the Company's United States, United Kingdom and Mexico manufacturing operations supporting the sale of OTC pharmaceutical products. Perrigo CHC supplies more than 15 categories and 500 formulas and offers analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as w! ell as vitamins, dietary supplements and nutritional drinks. Perrigo offers a range of products, such advertised brand products as Tylenol, Advil or One-A-Day. Tylenol has acetaminophen as an active ingredient and is available in stores' analgesic (pain reliever) aisle. Store-brand acetaminophen is located next to the national brand, offering the same active ingredient (acetaminophen) and the same pain relief.
Perrigo Nutritionals
Perrigo is a manufacturer of nutrition products for the store brand market. Nutrition products include infant formula, pediatric nutritionals and vitamins, minerals, and supplements. Acquired by Perrigo, Perrigo Nutritionals, formerly PBM Products, LLC, had introduced private-label, or store-brand infant formulas to the United States. Perrigo Nutritionals is the supplier of store-brand infant formulas and nutrition products. With distribution to major retailers, Perrigo Nutritional products can be found in more than 40,000 retail locations around the world. Its pediatric nutritionals business extends its offerings to children well beyond infancy. Its baby cereals, toddler foods, and pediatric nutritional drinks are available as store brands at various retail locations throughout the United States and the international community. Perrigo manufactures a range of vitamins, minerals, and supplements, in every major segment of the business. Marketed under the store brand labels of the retailers in the food, drug, mass-merchandise and wholesale club channels, it manufactures over 395 formulas of dietary supplements. Its brands include Centrum, One-A-Day, Flintstones, and Osteo-Bi-Flex.
Rx Pharmaceuticals
The Company�� Rx Pharmaceuticals business is focused on the development, manufacture and sale of generic prescription drug products, primarily for the United States market. Manufacturing operations are based in the United States and Israel. Perrigo's portfolio focuses on complex, high-barrier ophthalmological, topical foam and or! al liquid! formulations. Its products include Acetylcysteine Injection 200 mg/mL (6g/30mL), Acetylcysteine Injection 6 g/30 mL (200 mg/1 mL), NOVAPLUS, ACTIDOSE with SORBITOL, ACTIDOSE-AQUA, ASPIRIN SUPPOSITORIES USP, Bacitracin Ophthalmic Ointment USP, Belladonna and Opium Suppositories C-II, BENZOIN COMPOUND TINCTURE USP, Benzoyl Peroxide 10% Acne Medication Wash, CLOBETASOL PROPIONATE LOTION 0.05% and Docusate Sodium.
Active Pharmaceutical Ingredients
Primarily through the Company�� Israel-based business, Perrigo develops, manufactures and markets the complex chemicals and active pharmaceutical ingredients used worldwide by the generic drug industry. Certain of these ingredients are also used in Perrigo's own pharmaceutical products. It manufactures API at facilities in Israel, India and China. Perrigo API specializes in tailor-made research and process development of APIs and Finished Dosage Forms (FDFs).
Life Sciences
Through the Company�� Israel-based business, Perrigo markets and manufactures branded prescription drugs and medical diagnostic products through exclusive agreements with pharmaceutical companies. Its Pharmaceutical and Medical Diagnostic Products businesses also market and manufacture branded prescription drugs under licenses. Other pharmaceutical and medical diagnostics products are imported to Israel through exclusive agreements. Products in life sciences segment include TYSABRI and ELND005. TYSABRI (natalizumab) is indicated for treatment of: Multiple Sclerosis: as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. TYSABRI is recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate MS therapy; Crohn�� Disease (CD): Inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn�� disease with e! vidence o! f inflammation who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of tumor necrosis factor-伪.
Other
Perrigo's Pharmaceutical and Medical Diagnostic Products business markets and manufactures branded prescription drugs under licenses. Other pharmaceutical and medical diagnostic products are imported to Israel through exclusive agreements with pharmaceutical and diagnostics companies. This business is divided into two departments: Pharma-Israel and Tayco Diagnostics. Pharma-Israel operates in the Israeli market as a partner in the marketing, sales and distribution of Rx (dermatology, gastroenterology, blood products, CNS, urology and other fields), OTC, generics, branded generics, dermo-cosmetics and dietary supplements. Tayco, the diagnostics division of Perrigo-Israel Pharmaceuticals Ltd., specializes in marketing and sales of medical laboratory systems, reagents, accessories and consumables. It also markets self-monitoring medical devices for diagnosis and treatment of diabetes. The division operates throughout Israel to service the central laboratory, hospital, clinic, point of care and self-testing markets. Its activities in the medical and research fields in Israel cover all market segments: medical (private and public health services), research institutions and the biotech industry.
The Company competes with Dr. Reddy�� Laboratories, Ltd., Actavis Inc., Aaron Industries, Inc., Ohm Laboratories, Inc., PL Developments, LNK International, Inc., Abbott Laboratories, Mead Johnson Nutrition Co., Nestle S.A. (Gerber), Danone Baby Nutrition, Bayer AG, Pfizer, Inc., Rexall Sundown, Inc., Apotex, Glenmark Generics Inc., Impax, Prasco, Sandoz, Taro Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Triax Pharmaceuticals, and Zydus Pharmaceuticals.
Advisors' Opinion:- [By Benjamin Shepherd]
When you have a run-of-the-mill headache or cold, you take an aspirin or an antihistamine which you most likely picked up off a shelf at your pharmacy. You don�� see a doctor, you don�� have to talk to the pharmacist and you definitely don�� need a prescription for an over-the-counter (OTC) medication, some of which you might even take on a daily basis.
According to a paper from the American College of Preventative Medicine released in 2011, more than $17 billion of OTC products were sold in 2010 and more than a third of American adults reported using OTC medication on a regular basis. A survey conducted in 1999 showed that nearly 20 percent of the population used an OTC pain medication in any given week.
While there is the risk that readily available medications may be misused, OTC products are commonly used because they allow fast and direct access to effective medication for a whole host of common ailments. They also have the added benefit of helping to reduce the pressure on our health care system by preventing needless doctor calls.
When you think of OTC medications many of the first to come to mind, such as Tylenol, Sudafed and Benadryl, are products made by Johnson & Johnson (NYSE: JNJ). But over the past decade ��especially since the turmoil of the Great Recession ��there has been a rise in ��eneric generics,��otherwise known as store brands.
Most OTC medications have been around for decades, in the case of aspirin more than a century, and as a result have virtually no patent protections. That means that competition in the space has always been fierce and most manufacturers invest heavily in building up brand reputation for effectiveness, making it a relatively low margin business to begin with.
The market has become even more competitive since retailers have realized that they can keep more money in their own pockets by contracting for the production of virtually identical products which can be sold un
Best Trucking Stocks To Invest In 2015: Susser Petroleum Partners LP (SUSP)
Susser Petroleum Partners LP is primarily engaged in fee-based wholesale distribution of motor fuels to Susser Holdings Corporation (SHC) and third parties. SHC operates over 540 retail convenience stores under its Stripes convenience store brand. In addition to distributing motor fuel, the Company also distributes other petroleum products, such as propane and lube oil, and it receive rental income from real estate that it lease or sublease. In January 2014, Susser Petroleum Partners LP announced the acquisition of the convenience store assets and fuel distribution contracts of Sac-N-Pac Stores, Inc. and 3W Warren Fuels, Ltd.
During the year ended December 31, 2011, the Company distributed 789.6 million gallons of motor fuel to Stripes convenience stores and 522.8 million gallons of motor fuel to other customers. It also distributes Chevron, CITGO, Conoco, Exxon, Mobil, Phillips 66, Shamrock, Shell, Texaco and Valero branded motor fuel, as well as unbranded motor fuel. In addition to distributing motor fuel, it also distributes other petroleum products, such as propane and lube oil.
Advisors' Opinion:- [By Robert Rapier]
Susser Petroleum Partners (NYSE: SUSP) engages in fee-based wholesale distribution of motor fuels. The partnership also distributes petroleum products like propane and lube oil, and receives rental income from real estate.
Best Trucking Stocks To Invest In 2015: 1st United Bancorp Inc (FUBC)
1st United Bancorp, Inc. (Bancorp) is a financial holding company. 1st United Bank, a Florida state chartered bank, is Bancorp�� wholly owned subsidiary. The Company offers its customers, professionals, high net-worth individuals and small and medium-sized businesses, a variety of traditional loan, deposit and cash management products. As of December 31, 2010, Bancorp operated banking center from 15 locations consisting of four banking centers in Palm Beach County, four banking centers in Broward County, four banking centers in Miami-Dade County, and one banking center each in Sebastian, Vero Beach and Barefoot Bay, Florida. As of December 31, 2010, the total assets of Bancorp were at 1.268 billion and the total loans of the Company were at $847.7 million. As of December 31, 2010, its total deposits were $1.064 billion. On January 8, 2011, the Company purchased all of the assets of The Bank of Miami, National Association (The Bank of Miami). Effective April 1, 2012, the Company merged with Anderen Financial, Inc. (Anderen), under which it acquired Anderen and its subsidiary, Anderen Bank. In July 2013, 1st United Bancorp Inc completed its acquisition by merger of Enterprise Bancorp Inc (EBI) and its wholly owned subsidiary Enterprise Bank of Florida.
Investment Activity
Bancorp�� investment portfolio includes several callable agency debentures, mortgage-backed securities, adjustable rate mortgage pass-throughs, and collateralized mortgage obligations. As of December 31, 2010, the investment portfolio of the Company was at $102,289, 000.
Lending Activity
Bancorp offers a range of loans to its customers. The Company includes commercial loans, which include collateralized loans for working capital (including inventory and receivables), business expansion (including real estate construction, acquisitions and improvements), and purchase of equipment and machinery; small business loans, including small business administration (SBA) lending; Export-Im! port Bank insured or guaranteed loans; residential real estate loans to enable borrowers to purchase, refinance, construct upon or improve real property, and home equity loans, and consumer loans, including collateralized and uncollateralized loans for financing automobiles, boats, home improvements, and personal investments. As of December 31, 2010, the Company�� Commercial and Industrial loans were approximately $10.3 million, in Export Import (EXIM) loans which have either insurance or a guarantee of between 90% and 100% from the Export-Import Bank of the United States.
Through the Company�� lending division and SBA division, its commercial real estate loan portfolio includes loans secured by office buildings, warehouses, retail stores and other properties, which are located in or near the markets. Commercial real estate loans are generally originated in amounts up to 80% of the appraised value of the property securing the loan. It originates a mix of fixed rate and adjustable rate residential mortgage loans. It offers adjustable rate mortgages (ARMs), and maintains these ARMs in the portfolio or sells the ARMs in the secondary market.
The construction loan portfolio includes residential real estate, commercial real estate and homeowners��association projects. Through the business lending divisions, the Company offers real estate construction loans to individuals for the construction of their residences, to businesses and business owners primarily for owner-occupied, commercial real estate, and to homeowners��associations for general repair and/or improvements to the properties. The Company has construction loans on commercial real estate projects secured by industrial properties, office buildings or other property. The land loan portfolio includes exposure to land development, both residential and commercial. As of December 31, 2010, approximately $7.0 million or 21% of the construction and land development loan portfolio was part of the Loss Share Agreements.
T! he Company originates consumer loans bearing both fixed and prime-based variable interest rates. It originates the loans directly through the banking centers, business bankers and residential lenders. It focus the consumer lending on the origination of direct second mortgage loans and home equity loans (secured by a junior lien on residential real property), and home improvement loans. Second mortgage and home improvement loans generally originate on either a line of credit or a fixed term basis ranging from 5 to 15 years. It also extends personal loans, which may be secured by various forms of collateral, both real and personal, or to a minimal extent, on an unsecured basis.
The Company focus on the commercial loan market consists of small- to medium-sized businesses with combined borrowing needs up to $20.0 million. These businesses include professional associations (physicians, law firms, and accountants), medical services, retail trade, construction, transportation, wholesale trade, manufacturing, and tourism-related service industries. Its commercial loans are derived from the market area and underwritten on the basis of the borrowers��ability to service, such debt from recurring income. The EXIM lending operation makes loans to companies that export United States goods and services to international markets and makes loans to foreign companies to facilitate the purchase of United States goods. As of December 31, 2010, it had approximately $10.3 million in Exim loans.
Deposits
Bancorp maintains a range of deposit accounts to meet the needs of the residents and businesses in the primary service area. Products include an array of checking account programs for individuals and small businesses, including money market accounts, certificates of deposit, individual retirement account (IRA) accounts, and sweep investment capabilities. As of December 31, 2010, the Company had approximately $309.5 million in deposits by foreign nationals banking in the United States. A! s of Dece! mber 31, 2010, it had approximately $70 million in wholesale certificates of deposit.
The Company competes with Bank of America, SunTrust Bank, Wells Fargo, JP Morgan Chase & Co., BB&T, PNC, Citigroup and BankUnited, Inc.
Advisors' Opinion:- [By Marc Bastow]
The biggest increase among our dividend stocks this week came from Boca Raton, Florida-based financial holding company 1st United Bancorp (FUBC), who raised its quarterly dividend 100% to 2 cents per share, payable March 7 to shareholders of record as of Feb. 24.
FUBC Dividend Yield: 1.07%
Best Trucking Stocks To Invest In 2015: International Star Inc (ILST)
International Star, Inc., incorporated October 28, 1993, is primarily engaged in the acquisition and exploration of precious and base metals mineral properties. The Company�� properties are located in Arizona. As of December 31, 2010, the Company held 43 claims in the adjacent northern Black Mountains in Mohave County, and its current exploration activities are focused on these claims and surrounding areas of interest. As of September 1, 2010, the Company no longer held any mining claims in its former Wikieup property. The Wikieup Property formerly consisted of 42 lode claims comprising approximately 840 acres in the Hualapai Mountain Range at Wikieup, Arizona.
Mohave County, Arizona Property
The mineral property consists of approximately 1.4 square miles of land located in the northern Black Mountains in Mohave County, Arizona, approximately 56 miles from Las Vegas, Nevada, and 22 miles south of the Hoover Dam on United States Highway 93 (the Black Mountains Property). The property is easily accessed by partially paved entry off Highway 93 and has availability to electricity and water. Its Black Mountains Property consists of approximately 43 lode claims. Its claim holdings in this area began with placer claims in the adjacent Detrital Wash area. The Black Mountains Property is underlain by three basic rock units or packages of rocks. The oldest rock unit consists of Precambrian schist and gneissic rocks, which are the reconstituted (metamorphic) equivalents of former shale, siltstone, and volcanic rocks.
The property exhibits features of a metamorphic core complex. These features include the somewhat arch-like, cross-sectional (east-west) profile of this area of the Black Mountains, detached cover rocks, a preponderance of shallow-dipping penetrative structures (foliations) in the plutonic/metamorphic basement, and the composition of the plutonic rocks. The Company�� exploration efforts are primarily focused on the establishment of gold reserves with a seco! ndary focus on copper and other minerals. During the year ended December 1, 2010, the Company conducted drilling and additional sampling and mapping work on certain areas of its Black Mountains Property showing high mineralization results. During 2010, it allowed approximately 60 of its previously filed claims to expire and added approximately 25 claims covering nearby areas.
Advisors' Opinion:- [By Peter Graham]
Small cap mining stocks International Star Inc (OTCMKTS: ILST) and Mining Minerals of Mexico Corp (OTCMKTS: WIIM) sank 13.33% and 24.9%, respectively, today, with at least one of these small cap stocks being the subject of paid promotions or investor relations type of activities while the other has had no news since last summer. So should you dig into these small cap mining stocks which just dug a hole for investors and traders alike? Here is a closer look to help you decide:
Best Trucking Stocks To Invest In 2015: Pitney Bowes Inc(PBI)
Pitney Bowes Inc. provides mail processing equipment and integrated mail solutions worldwide. It offers a suite of equipment, supplies, software, services, and solutions for managing and integrating physical and digital communication channels. The company?s Small & Medium Business Solutions group engages in the sale, rental, and financing of mail finishing, mail creation, and shipping equipment and software; provision of supply, support, and other professional services; and provision of payment solutions. Its Enterprise Business Solutions group sells, supports, and offers other professional services for high-speed production mail systems, and sorting and production print equipment; and sells and provides support services for non-equipment-based mailing, customer relationship and communication, and location intelligence software. This group also offers facilities management services; secure mail services; reprographic document management services; and litigation support and eDiscovery services, as well as provides presort mail services and cross-border mail services; and direct marketing services. Pitney Bowes Inc. markets its products and services through its sales force, direct mailings, outbound telemarketing, and independent distributors and dealers to various business, governmental, institutional, and other organizations. The company, formerly known as Pitney Bowes Postage Meter Company, was founded in 1920 and headquartered in Stamford, Connecticut.
Advisors' Opinion:- [By Dan Caplinger]
You can find many examples of this phenomenon recently:
Late last month, Pitney Bowes (NYSE: PBI ) cut its dividend in half after announcing worse-than-expected sales and income. The stock had suffered from weakness in Pitney Bowes' core mailing and enterprise business solutions segments, and the company chose to sacrifice its former double-digit yield in order to shore up its financial condition. Even after the cut, the stock still yields a fairly high 5%. In February, CenturyLink (NYSE: CTL ) cut its dividend by about 25%, again after reporting weak guidance for its earnings for the remainder of 2013. Even though the rural telecom company chose simply to put cash previously earmarked to pay its former yield of 7% toward share buybacks instead, the stock plunged more than 20% in response to the move, although it has rebounded significantly since then as investors recognized the fundamental benefits to the company from the capital reallocation. Until three months ago, Cliffs Natural Resources (NYSE: CLF ) had a high dividend yield approaching 7% despite terrible conditions in its iron-ore and metallurgical-coal businesses. After announcing earnings in mid-February, the company cut its dividend by more than three-quarters in a move that will conserve cash for the ailing producer of raw materials for steel production. Now, the stock yields just 2.6%.That's not to say that all of the highest dividend paying stocks are doomed to reduce their payouts. Businesses that are designed to focus on maximizing cash flow rather than seeking growth can often sustain very high yields for years. Vanguard High Dividend Yield (NYSEMKT: VYM ) and other dividend ETFs use a combination of factors beyond simple yield to choose stocks with sustainable high payouts.
Best Trucking Stocks To Invest In 2015: Amicus Therapeutics Inc.(FOLD)
Amicus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs for the treatment of various human genetic diseases. Its drugs are known as pharmacological chaperones, which selectively bind to the target protein, enhance the stability of the protein, help it fold into the three-dimensional shape, and allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. The company primarily focuses on lysosomal storage disorders and diseases of neurodegeneration. Its products under development include Amigal, which is in phase III for the treatment of Fabry disease; AT2220, which completed phase I study for the treatment of Pompe disease; and Plicera, that has completed phase I study for the treatment of Gaucher disease. The company has license and collaboration agreement with Glaxo Group Limited to develop and commerc ialize Amigal. The company was founded in 2002 and is based in Cranbury, New Jersey.
Advisors' Opinion:- [By Rick Munarriz]
5. You've got to know when to FOLD 'em
Investing in biotech upstarts can be pretty risky, and Amicus Therapeutics (NASDAQ: FOLD ) investors learned that the hard way this week.
No comments:
Post a Comment